

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 9.80089452 |
| 2 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 6.67388464 |
| 3 | response to prostaglandin E (GO:0034695) | 5.27281105 |
| 4 | positive regulation of cell size (GO:0045793) | 4.97945445 |
| 5 | sphingosine metabolic process (GO:0006670) | 4.89978693 |
| 6 | diol metabolic process (GO:0034311) | 4.59673887 |
| 7 | sphingoid metabolic process (GO:0046519) | 4.59411544 |
| 8 | myeloid dendritic cell differentiation (GO:0043011) | 4.49071276 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 4.37195340 |
| 10 | growth hormone receptor signaling pathway (GO:0060396) | 4.20451720 |
| 11 | negative regulation of necroptotic process (GO:0060546) | 4.17759002 |
| 12 | behavioral response to nicotine (GO:0035095) | 4.11729360 |
| 13 | regulation of RIG-I signaling pathway (GO:0039535) | 4.10940147 |
| 14 | T-helper cell differentiation (GO:0042093) | 4.10520229 |
| 15 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.10520229 |
| 16 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.06403905 |
| 17 | positive regulation of developmental pigmentation (GO:0048087) | 3.98168436 |
| 18 | response to prostaglandin (GO:0034694) | 3.97648443 |
| 19 | interferon-gamma secretion (GO:0072643) | 3.96661874 |
| 20 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.92021777 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.90661840 |
| 22 | positive regulation of filopodium assembly (GO:0051491) | 3.80510169 |
| 23 | dendritic cell differentiation (GO:0097028) | 3.79755024 |
| 24 | neuron recognition (GO:0008038) | 3.78657724 |
| 25 | axonal fasciculation (GO:0007413) | 3.78309547 |
| 26 | cell migration in hindbrain (GO:0021535) | 3.77837993 |
| 27 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.64827502 |
| 28 | ganglion development (GO:0061548) | 3.63695629 |
| 29 | DNA methylation involved in gamete generation (GO:0043046) | 3.62595593 |
| 30 | cellular response to growth hormone stimulus (GO:0071378) | 3.59797087 |
| 31 | regulation of antigen processing and presentation (GO:0002577) | 3.58285885 |
| 32 | myeloid dendritic cell activation (GO:0001773) | 3.57583821 |
| 33 | cellular response to prostaglandin stimulus (GO:0071379) | 3.57335073 |
| 34 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.56939121 |
| 35 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.55222557 |
| 36 | T cell differentiation involved in immune response (GO:0002292) | 3.55222557 |
| 37 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.55222557 |
| 38 | regulation of pigment cell differentiation (GO:0050932) | 3.51275743 |
| 39 | regulation of protein glycosylation (GO:0060049) | 3.47187510 |
| 40 | regulation of necroptotic process (GO:0060544) | 3.44522784 |
| 41 | muscle filament sliding (GO:0030049) | 3.41063527 |
| 42 | actin-myosin filament sliding (GO:0033275) | 3.41063527 |
| 43 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40563670 |
| 44 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.36535340 |
| 45 | negative regulation of necrotic cell death (GO:0060547) | 3.34174263 |
| 46 | myofibril assembly (GO:0030239) | 3.33608685 |
| 47 | postsynaptic membrane organization (GO:0001941) | 3.25449813 |
| 48 | protein-chromophore linkage (GO:0018298) | 3.24407836 |
| 49 | regulation of skeletal muscle contraction (GO:0014819) | 3.23724839 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.23481272 |
| 51 | regulation of meiosis I (GO:0060631) | 3.22232852 |
| 52 | necroptotic process (GO:0070266) | 3.20226077 |
| 53 | protein polyglutamylation (GO:0018095) | 3.10565329 |
| 54 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.08420803 |
| 55 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.06800022 |
| 56 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.05195833 |
| 57 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.05195833 |
| 58 | skeletal muscle adaptation (GO:0043501) | 3.03180550 |
| 59 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.02489357 |
| 60 | neutrophil activation (GO:0042119) | 2.99311913 |
| 61 | nucleobase catabolic process (GO:0046113) | 2.93927799 |
| 62 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.93526209 |
| 63 | positive regulation of neutrophil migration (GO:1902624) | 2.93526209 |
| 64 | sulfate transmembrane transport (GO:1902358) | 2.93192960 |
| 65 | DNA deamination (GO:0045006) | 2.92986395 |
| 66 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.92486444 |
| 67 | response to inactivity (GO:0014854) | 2.90251090 |
| 68 | fucose catabolic process (GO:0019317) | 2.90188515 |
| 69 | L-fucose metabolic process (GO:0042354) | 2.90188515 |
| 70 | L-fucose catabolic process (GO:0042355) | 2.90188515 |
| 71 | piRNA metabolic process (GO:0034587) | 2.89588381 |
| 72 | secondary heart field specification (GO:0003139) | 2.88851533 |
| 73 | heart field specification (GO:0003128) | 2.88851533 |
| 74 | neural tube formation (GO:0001841) | 2.87926736 |
| 75 | negative thymic T cell selection (GO:0045060) | 2.86890298 |
| 76 | negative regulation of telomere maintenance (GO:0032205) | 2.85023087 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.84715092 |
| 78 | response to pheromone (GO:0019236) | 2.81271657 |
| 79 | regulation of telomere maintenance (GO:0032204) | 2.80492765 |
| 80 | regulation of sarcomere organization (GO:0060297) | 2.78920773 |
| 81 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.78794955 |
| 82 | actin-mediated cell contraction (GO:0070252) | 2.78307774 |
| 83 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.78221248 |
| 84 | positive regulation of interleukin-12 production (GO:0032735) | 2.78048084 |
| 85 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.77718185 |
| 86 | axon extension (GO:0048675) | 2.77484785 |
| 87 | response to nitric oxide (GO:0071731) | 2.74967952 |
| 88 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.74277272 |
| 89 | olfactory bulb development (GO:0021772) | 2.71807348 |
| 90 | neuronal action potential propagation (GO:0019227) | 2.71424759 |
| 91 | snRNA transcription (GO:0009301) | 2.71330143 |
| 92 | membrane depolarization during action potential (GO:0086010) | 2.71246293 |
| 93 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.70638959 |
| 94 | indolalkylamine metabolic process (GO:0006586) | 2.69554014 |
| 95 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.69297020 |
| 96 | response to muscle activity (GO:0014850) | 2.68674345 |
| 97 | presynaptic membrane assembly (GO:0097105) | 2.68655056 |
| 98 | retinal ganglion cell axon guidance (GO:0031290) | 2.68357824 |
| 99 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.67761959 |
| 100 | sarcomere organization (GO:0045214) | 2.66806098 |
| 101 | cardiac myofibril assembly (GO:0055003) | 2.65337711 |
| 102 | granulocyte activation (GO:0036230) | 2.65305700 |
| 103 | spinal cord motor neuron differentiation (GO:0021522) | 2.65015855 |
| 104 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.64310504 |
| 105 | adaptation of signaling pathway (GO:0023058) | 2.63241463 |
| 106 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.62463555 |
| 107 | dendrite morphogenesis (GO:0048813) | 2.61419727 |
| 108 | retinal cone cell development (GO:0046549) | 2.60519911 |
| 109 | myoblast migration (GO:0051451) | 2.60308031 |
| 110 | sympathetic nervous system development (GO:0048485) | 2.59672933 |
| 111 | neuron cell-cell adhesion (GO:0007158) | 2.59598848 |
| 112 | positive regulation of heat generation (GO:0031652) | 2.59272375 |
| 113 | auditory behavior (GO:0031223) | 2.58190517 |
| 114 | peristalsis (GO:0030432) | 2.57766326 |
| 115 | muscle atrophy (GO:0014889) | 2.57596025 |
| 116 | synaptic transmission, cholinergic (GO:0007271) | 2.57364910 |
| 117 | central nervous system neuron axonogenesis (GO:0021955) | 2.56892497 |
| 118 | natural killer cell mediated immunity (GO:0002228) | 2.56708266 |
| 119 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.56708266 |
| 120 | negative T cell selection (GO:0043383) | 2.56570084 |
| 121 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.55958107 |
| 122 | synaptic transmission, glutamatergic (GO:0035249) | 2.55327014 |
| 123 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.55282947 |
| 124 | necrotic cell death (GO:0070265) | 2.55088452 |
| 125 | regulation of vesicle fusion (GO:0031338) | 2.55030822 |
| 126 | sulfate transport (GO:0008272) | 2.54845054 |
| 127 | striated muscle atrophy (GO:0014891) | 2.54666509 |
| 128 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.54653193 |
| 129 | gamma-aminobutyric acid transport (GO:0015812) | 2.54599260 |
| 130 | regulation of filopodium assembly (GO:0051489) | 2.54112266 |
| 131 | skeletal muscle contraction (GO:0003009) | 2.53798955 |
| 132 | organelle disassembly (GO:1903008) | 2.53657516 |
| 133 | somite development (GO:0061053) | 2.53193254 |
| 134 | behavioral response to ethanol (GO:0048149) | 2.52530243 |
| 135 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.52281159 |
| 136 | mechanosensory behavior (GO:0007638) | 2.52118392 |
| 137 | positive regulation of meiosis (GO:0045836) | 2.52108375 |
| 138 | regulation of cellular extravasation (GO:0002691) | 2.51941586 |
| 139 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.51549333 |
| 140 | regulation of cell communication by electrical coupling (GO:0010649) | 2.51227786 |
| 141 | regulation of action potential (GO:0098900) | 2.51112942 |
| 142 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.51020720 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.50928489 |
| 144 | regulation of glucokinase activity (GO:0033131) | 2.50928489 |
| 145 | presynaptic membrane organization (GO:0097090) | 2.50766586 |
| 146 | phasic smooth muscle contraction (GO:0014821) | 2.50179379 |
| 147 | ribonucleoprotein complex disassembly (GO:0032988) | 2.50077826 |
| 148 | glutamate receptor signaling pathway (GO:0007215) | 2.50035088 |
| 149 | kynurenine metabolic process (GO:0070189) | 2.49970424 |
| 150 | pyrimidine dimer repair (GO:0006290) | 2.49949380 |
| 151 | regulation of T cell tolerance induction (GO:0002664) | 2.49789185 |
| 152 | facial nerve structural organization (GO:0021612) | 2.48369735 |
| 153 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.48139663 |
| 154 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.47064415 |
| 155 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.46553682 |
| 156 | axon extension involved in axon guidance (GO:0048846) | 2.46553682 |
| 157 | tryptophan catabolic process (GO:0006569) | 2.46317275 |
| 158 | indole-containing compound catabolic process (GO:0042436) | 2.46317275 |
| 159 | indolalkylamine catabolic process (GO:0046218) | 2.46317275 |
| 160 | dendritic cell chemotaxis (GO:0002407) | 2.46023341 |
| 161 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.45600772 |
| 162 | neuronal action potential (GO:0019228) | 2.45394651 |
| 163 | opioid receptor signaling pathway (GO:0038003) | 2.45026820 |
| 164 | programmed necrotic cell death (GO:0097300) | 2.44351786 |
| 165 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.43936876 |
| 166 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.43936876 |
| 167 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.43936876 |
| 168 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.43466217 |
| 169 | response to muramyl dipeptide (GO:0032495) | 2.43127397 |
| 170 | regulation of protein polyubiquitination (GO:1902914) | 2.43015526 |
| 171 | plasma membrane repair (GO:0001778) | 2.42845493 |
| 172 | intraciliary transport (GO:0042073) | 2.42218444 |
| 173 | regulation of protein oligomerization (GO:0032459) | 2.42042268 |
| 174 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.40938384 |
| 175 | regulation of energy homeostasis (GO:2000505) | 2.40878256 |
| 176 | kidney morphogenesis (GO:0060993) | 2.39970941 |
| 177 | regulation of fever generation (GO:0031620) | 2.39549649 |
| 178 | positive regulation of protein oligomerization (GO:0032461) | 2.39542263 |
| 179 | neuromuscular synaptic transmission (GO:0007274) | 2.39534103 |
| 180 | interkinetic nuclear migration (GO:0022027) | 2.39033297 |
| 181 | histone H3-K36 demethylation (GO:0070544) | 2.36540627 |
| 182 | limb bud formation (GO:0060174) | 2.36531510 |
| 183 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.36451771 |
| 184 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.35639041 |
| 185 | positive regulation of protein homooligomerization (GO:0032464) | 2.33215605 |
| 186 | dendritic spine morphogenesis (GO:0060997) | 2.31674355 |
| 187 | glial cell proliferation (GO:0014009) | 2.31065360 |
| 188 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.31022360 |
| 189 | neuron projection extension (GO:1990138) | 2.29221820 |
| 190 | dendritic cell migration (GO:0036336) | 2.26961298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.53780722 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.32704450 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.13624330 |
| 4 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 2.89210991 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.84916086 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37734401 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33373856 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.30466037 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.25869909 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.22027621 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13224626 |
| 12 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.11820073 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06507801 |
| 14 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.05652737 |
| 15 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98995208 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.98694769 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.98694769 |
| 18 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94347989 |
| 19 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.92383793 |
| 20 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.90510814 |
| 21 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90510814 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87502329 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80935528 |
| 24 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78208291 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76934795 |
| 26 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76251480 |
| 27 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75387505 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.75339181 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.75221607 |
| 30 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.74998756 |
| 31 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.73668166 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70862930 |
| 33 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70089789 |
| 34 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.64277564 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64131492 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61787658 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59164870 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57596663 |
| 39 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.57461128 |
| 40 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.55799226 |
| 41 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.54029878 |
| 42 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.52865009 |
| 43 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.52837979 |
| 44 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47947847 |
| 45 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.47918502 |
| 46 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47240737 |
| 47 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.47240737 |
| 48 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46446985 |
| 49 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41361122 |
| 50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40726993 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40411819 |
| 52 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38185914 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37333486 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.37026479 |
| 55 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.36890337 |
| 56 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36632292 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35882694 |
| 58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35557329 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34798243 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34680180 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32066576 |
| 62 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31653647 |
| 63 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29942892 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29613639 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29251278 |
| 66 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.29102663 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27807187 |
| 68 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27807187 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27622361 |
| 70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.27468331 |
| 71 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26505247 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26405381 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26209777 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25529582 |
| 75 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24991216 |
| 76 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24532625 |
| 77 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21619634 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21417649 |
| 79 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.21083188 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.21072805 |
| 81 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.20755751 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20715348 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20493600 |
| 84 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19424058 |
| 85 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.18809341 |
| 86 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18663338 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18602017 |
| 88 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18228619 |
| 89 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17894647 |
| 90 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.17833508 |
| 91 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17500511 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17113968 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16889805 |
| 94 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16640072 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16101442 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.15752118 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14850340 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14013237 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13723029 |
| 100 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.13113223 |
| 101 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.13009103 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12918798 |
| 103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12371375 |
| 104 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11695204 |
| 105 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11381076 |
| 106 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11328582 |
| 107 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.11258362 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11199913 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10249972 |
| 110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09194242 |
| 111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09156471 |
| 112 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06727495 |
| 113 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06660495 |
| 114 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05761179 |
| 115 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05332682 |
| 116 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05270862 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04898593 |
| 118 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04683790 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04142887 |
| 120 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04094208 |
| 121 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03996206 |
| 122 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03491121 |
| 123 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03363990 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03120912 |
| 125 | * AR_19668381_ChIP-Seq_PC3_Human | 1.02778028 |
| 126 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02333200 |
| 127 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02002199 |
| 128 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01803629 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01696137 |
| 130 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01374156 |
| 131 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00699261 |
| 132 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00320931 |
| 133 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99897221 |
| 134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99488709 |
| 135 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99050126 |
| 136 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98965821 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98352261 |
| 138 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98275577 |
| 139 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97915550 |
| 140 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97654001 |
| 141 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97059782 |
| 142 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96803602 |
| 143 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96691381 |
| 144 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96488184 |
| 145 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95705986 |
| 146 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94386787 |
| 147 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93342057 |
| 148 | TBL1_22424771_ChIP-Seq_293T_Human | 0.93207934 |
| 149 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.93135563 |
| 150 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92987883 |
| 151 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.92983994 |
| 152 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92483065 |
| 153 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91328323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 8.69110410 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 5.15225189 |
| 3 | MP0004510_myositis | 4.57355185 |
| 4 | MP0001348_abnormal_lacrimal_gland | 4.52062385 |
| 5 | MP0000569_abnormal_digit_pigmentation | 4.38539077 |
| 6 | MP0001346_abnormal_lacrimal_gland | 4.07636818 |
| 7 | MP0003136_yellow_coat_color | 3.28424752 |
| 8 | MP0002009_preneoplasia | 2.96634869 |
| 9 | MP0000685_abnormal_immune_system | 2.70808572 |
| 10 | MP0002277_abnormal_respiratory_mucosa | 2.70094749 |
| 11 | MP0005171_absent_coat_pigmentation | 2.60792477 |
| 12 | MP0000778_abnormal_nervous_system | 2.60614999 |
| 13 | MP0003045_fibrosis | 2.58921393 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.58237303 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.35274089 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.28729124 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.20680266 |
| 18 | MP0005310_abnormal_salivary_gland | 2.19957418 |
| 19 | MP0003880_abnormal_central_pattern | 2.10657847 |
| 20 | MP0002163_abnormal_gland_morphology | 2.04420055 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.95804588 |
| 22 | MP0005423_abnormal_somatic_nervous | 1.89830628 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.80645117 |
| 24 | MP0004142_abnormal_muscle_tone | 1.78107032 |
| 25 | MP0001873_stomach_inflammation | 1.75171819 |
| 26 | MP0002822_catalepsy | 1.69019727 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.65393467 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.59303212 |
| 29 | MP0009745_abnormal_behavioral_response | 1.57991250 |
| 30 | MP0001984_abnormal_olfaction | 1.57567480 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.57268811 |
| 32 | MP0004043_abnormal_pH_regulation | 1.55631888 |
| 33 | MP0002272_abnormal_nervous_system | 1.53204515 |
| 34 | MP0005253_abnormal_eye_physiology | 1.51797974 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.51568806 |
| 36 | MP0004859_abnormal_synaptic_plasticity | 1.42053627 |
| 37 | MP0003195_calcinosis | 1.41821540 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.41311518 |
| 39 | MP0003787_abnormal_imprinting | 1.41049447 |
| 40 | MP0000537_abnormal_urethra_morphology | 1.38902741 |
| 41 | MP0002184_abnormal_innervation | 1.35698261 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.33904068 |
| 43 | MP0001529_abnormal_vocalization | 1.29725310 |
| 44 | MP0003890_abnormal_embryonic-extraembry | 1.27507972 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.26239399 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.25982730 |
| 47 | MP0002269_muscular_atrophy | 1.24976143 |
| 48 | MP0004270_analgesia | 1.23953116 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.21402170 |
| 50 | MP0004924_abnormal_behavior | 1.21402170 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.19512738 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.18880989 |
| 53 | MP0001790_abnormal_immune_system | 1.17620496 |
| 54 | MP0005387_immune_system_phenotype | 1.17620496 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 1.17069167 |
| 56 | MP0002006_tumorigenesis | 1.16018968 |
| 57 | MP0005670_abnormal_white_adipose | 1.15794547 |
| 58 | MP0002064_seizures | 1.15301811 |
| 59 | MP0002102_abnormal_ear_morphology | 1.13086629 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.11118898 |
| 61 | MP0000733_abnormal_muscle_development | 1.10029175 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.08591103 |
| 63 | MP0008057_abnormal_DNA_replication | 1.08272888 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.07684128 |
| 65 | MP0004130_abnormal_muscle_cell | 1.06584793 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.06207273 |
| 67 | MP0002736_abnormal_nociception_after | 1.03843879 |
| 68 | MP0000538_abnormal_urinary_bladder | 1.03456988 |
| 69 | MP0001970_abnormal_pain_threshold | 1.03191325 |
| 70 | MP0000751_myopathy | 1.02779271 |
| 71 | MP0002168_other_aberrant_phenotype | 1.02428267 |
| 72 | MP0002234_abnormal_pharynx_morphology | 1.01073236 |
| 73 | MP0008872_abnormal_physiological_respon | 0.99927849 |
| 74 | MP0005266_abnormal_metabolism | 0.99512227 |
| 75 | MP0005367_renal/urinary_system_phenotyp | 0.98824243 |
| 76 | MP0000516_abnormal_urinary_system | 0.98824243 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.98031828 |
| 78 | MP0008789_abnormal_olfactory_epithelium | 0.96075797 |
| 79 | MP0003091_abnormal_cell_migration | 0.95691290 |
| 80 | MP0004858_abnormal_nervous_system | 0.94684450 |
| 81 | MP0005330_cardiomyopathy | 0.93477149 |
| 82 | MP0000613_abnormal_salivary_gland | 0.93449265 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.91246429 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.88630565 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.87969791 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.87572975 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.86877414 |
| 88 | MP0002938_white_spotting | 0.85649350 |
| 89 | MP0004885_abnormal_endolymph | 0.85172149 |
| 90 | MP0004381_abnormal_hair_follicle | 0.84851283 |
| 91 | MP0002106_abnormal_muscle_physiology | 0.84482824 |
| 92 | MP0003121_genomic_imprinting | 0.83813465 |
| 93 | MP0000427_abnormal_hair_cycle | 0.83110311 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.83084515 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.82374571 |
| 96 | MP0004085_abnormal_heartbeat | 0.82335947 |
| 97 | MP0004084_abnormal_cardiac_muscle | 0.77055557 |
| 98 | MP0004233_abnormal_muscle_weight | 0.76165484 |
| 99 | MP0005187_abnormal_penis_morphology | 0.75800796 |
| 100 | MP0003879_abnormal_hair_cell | 0.75458885 |
| 101 | MP0002063_abnormal_learning/memory/cond | 0.75196007 |
| 102 | MP0005195_abnormal_posterior_eye | 0.74749349 |
| 103 | MP0001188_hyperpigmentation | 0.74395006 |
| 104 | MP0005671_abnormal_response_to | 0.73991847 |
| 105 | MP0003385_abnormal_body_wall | 0.73589398 |
| 106 | MP0002734_abnormal_mechanical_nocicepti | 0.73057808 |
| 107 | MP0004147_increased_porphyrin_level | 0.73048708 |
| 108 | MP0002229_neurodegeneration | 0.72464197 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.71976771 |
| 110 | MP0004145_abnormal_muscle_electrophysio | 0.71939239 |
| 111 | MP0004484_altered_response_of | 0.70960014 |
| 112 | MP0003635_abnormal_synaptic_transmissio | 0.70284814 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 0.69023790 |
| 114 | MP0004811_abnormal_neuron_physiology | 0.67205028 |
| 115 | MP0002148_abnormal_hypersensitivity_rea | 0.66139192 |
| 116 | MP0003646_muscle_fatigue | 0.65114954 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.64792855 |
| 118 | MP0005379_endocrine/exocrine_gland_phen | 0.64432019 |
| 119 | MP0005620_abnormal_muscle_contractility | 0.62749414 |
| 120 | MP0001299_abnormal_eye_distance/ | 0.61133438 |
| 121 | MP0002882_abnormal_neuron_morphology | 0.60080115 |
| 122 | MP0003861_abnormal_nervous_system | 0.60040727 |
| 123 | MP0005499_abnormal_olfactory_system | 0.59647410 |
| 124 | MP0005394_taste/olfaction_phenotype | 0.59647410 |
| 125 | MP0003315_abnormal_perineum_morphology | 0.59277293 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.59172000 |
| 127 | MP0001800_abnormal_humoral_immune | 0.58818322 |
| 128 | MP0005369_muscle_phenotype | 0.58196073 |
| 129 | MP0001270_distended_abdomen | 0.57526781 |
| 130 | MP0002233_abnormal_nose_morphology | 0.57173062 |
| 131 | MP0000759_abnormal_skeletal_muscle | 0.56982325 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.54837330 |
| 133 | MP0004087_abnormal_muscle_fiber | 0.54612570 |
| 134 | MP0002733_abnormal_thermal_nociception | 0.54520944 |
| 135 | MP0006292_abnormal_olfactory_placode | 0.53748722 |
| 136 | MP0009046_muscle_twitch | 0.53370420 |
| 137 | MP0000579_abnormal_nail_morphology | 0.48951796 |
| 138 | MP0000026_abnormal_inner_ear | 0.48821343 |
| 139 | MP0003755_abnormal_palate_morphology | 0.48746624 |
| 140 | MP0003119_abnormal_digestive_system | 0.48598174 |
| 141 | MP0002152_abnormal_brain_morphology | 0.48426815 |
| 142 | MP0000470_abnormal_stomach_morphology | 0.48230351 |
| 143 | MP0000955_abnormal_spinal_cord | 0.47661629 |
| 144 | MP0000049_abnormal_middle_ear | 0.47055014 |
| 145 | MP0002116_abnormal_craniofacial_bone | 0.46762343 |
| 146 | MP0000749_muscle_degeneration | 0.46157493 |
| 147 | MP0004134_abnormal_chest_morphology | 0.46083922 |
| 148 | MP0003937_abnormal_limbs/digits/tail_de | 0.45639887 |
| 149 | MP0001486_abnormal_startle_reflex | 0.44826241 |
| 150 | MP0002972_abnormal_cardiac_muscle | 0.44358189 |
| 151 | MP0004133_heterotaxia | 0.43135025 |
| 152 | MP0002752_abnormal_somatic_nervous | 0.42475543 |
| 153 | MP0005248_abnormal_Harderian_gland | 0.41958116 |
| 154 | MP0002557_abnormal_social/conspecific_i | 0.41257995 |
| 155 | MP0002452_abnormal_antigen_presenting | 0.40937492 |
| 156 | MP0000767_abnormal_smooth_muscle | 0.40754036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.24835260 |
| 2 | Cortical dysplasia (HP:0002539) | 4.06444347 |
| 3 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74210145 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74210145 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 3.65147378 |
| 6 | Pancreatic cysts (HP:0001737) | 3.54058903 |
| 7 | Hyperventilation (HP:0002883) | 3.42931383 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.39143499 |
| 9 | Focal seizures (HP:0007359) | 3.36807291 |
| 10 | Type II lissencephaly (HP:0007260) | 3.20676317 |
| 11 | Nemaline bodies (HP:0003798) | 3.17672179 |
| 12 | Nephronophthisis (HP:0000090) | 3.11663493 |
| 13 | Increased IgE level (HP:0003212) | 3.10321907 |
| 14 | Keratoconjunctivitis (HP:0001096) | 3.07561954 |
| 15 | Exotropia (HP:0000577) | 3.05392525 |
| 16 | Dialeptic seizures (HP:0011146) | 2.99994357 |
| 17 | Abnormality of the renal cortex (HP:0011035) | 2.97508835 |
| 18 | Recurrent fungal infections (HP:0002841) | 2.96905714 |
| 19 | Abnormality of the gastric mucosa (HP:0004295) | 2.91378934 |
| 20 | Hydroxyprolinuria (HP:0003080) | 2.90186836 |
| 21 | Abnormality of proline metabolism (HP:0010907) | 2.90186836 |
| 22 | Exercise-induced muscle cramps (HP:0003710) | 2.86767888 |
| 23 | Proximal amyotrophy (HP:0007126) | 2.82863137 |
| 24 | Wrist flexion contracture (HP:0001239) | 2.78809106 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 2.76048808 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.76048808 |
| 27 | Amelogenesis imperfecta (HP:0000705) | 2.73957337 |
| 28 | Abnormality of the renal medulla (HP:0100957) | 2.73258314 |
| 29 | Lip pit (HP:0100267) | 2.68783671 |
| 30 | Colon cancer (HP:0003003) | 2.64931831 |
| 31 | Papillary thyroid carcinoma (HP:0002895) | 2.62141906 |
| 32 | Persistence of primary teeth (HP:0006335) | 2.60799762 |
| 33 | Myopathic facies (HP:0002058) | 2.59928856 |
| 34 | Cerebellar dysplasia (HP:0007033) | 2.58544628 |
| 35 | Inability to walk (HP:0002540) | 2.57229605 |
| 36 | Pancreatic fibrosis (HP:0100732) | 2.55437837 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 2.53510619 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 2.53451722 |
| 39 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.52512460 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.50036539 |
| 41 | Fatigue (HP:0012378) | 2.47391157 |
| 42 | Pachygyria (HP:0001302) | 2.44773598 |
| 43 | True hermaphroditism (HP:0010459) | 2.44338453 |
| 44 | Abnormality of the fingertips (HP:0001211) | 2.43928366 |
| 45 | Aplasia cutis congenita (HP:0001057) | 2.41633685 |
| 46 | Type 1 muscle fiber predominance (HP:0003803) | 2.40427774 |
| 47 | Exercise-induced myalgia (HP:0003738) | 2.38084801 |
| 48 | Calf muscle hypertrophy (HP:0008981) | 2.37758521 |
| 49 | Pendular nystagmus (HP:0012043) | 2.36716507 |
| 50 | Medial flaring of the eyebrow (HP:0010747) | 2.35812757 |
| 51 | Fatigable weakness (HP:0003473) | 2.35803077 |
| 52 | Abnormality of the neuromuscular junction (HP:0003398) | 2.35803077 |
| 53 | Shoulder girdle muscle weakness (HP:0003547) | 2.34435203 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.32901169 |
| 55 | Rimmed vacuoles (HP:0003805) | 2.30655612 |
| 56 | Lower limb amyotrophy (HP:0007210) | 2.29371581 |
| 57 | Optic neuritis (HP:0100653) | 2.28868027 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.28868027 |
| 59 | Gait imbalance (HP:0002141) | 2.27007015 |
| 60 | Myoglobinuria (HP:0002913) | 2.26414003 |
| 61 | Absent frontal sinuses (HP:0002688) | 2.26109678 |
| 62 | Urinary urgency (HP:0000012) | 2.25123261 |
| 63 | Renal cortical cysts (HP:0000803) | 2.24859506 |
| 64 | Febrile seizures (HP:0002373) | 2.23477832 |
| 65 | Gaze-evoked nystagmus (HP:0000640) | 2.20204135 |
| 66 | Difficulty running (HP:0009046) | 2.18890439 |
| 67 | Frequent falls (HP:0002359) | 2.17375239 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.17168501 |
| 69 | Progressive inability to walk (HP:0002505) | 2.14940292 |
| 70 | Intestinal atresia (HP:0011100) | 2.14756254 |
| 71 | Cystic liver disease (HP:0006706) | 2.14433406 |
| 72 | Abnormality of the intervertebral disk (HP:0005108) | 2.11535787 |
| 73 | Scapular winging (HP:0003691) | 2.11113680 |
| 74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.11022218 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.09542438 |
| 76 | Retinal dysplasia (HP:0007973) | 2.09234609 |
| 77 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.06554758 |
| 78 | Hypoplasia of the brainstem (HP:0002365) | 2.06554758 |
| 79 | Stomach cancer (HP:0012126) | 2.06433608 |
| 80 | Decreased circulating renin level (HP:0003351) | 2.06335745 |
| 81 | Hyperkalemia (HP:0002153) | 2.05319750 |
| 82 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.03316031 |
| 83 | Parakeratosis (HP:0001036) | 2.01519445 |
| 84 | Hypoplastic iliac wings (HP:0002866) | 2.00996657 |
| 85 | Absent speech (HP:0001344) | 1.99608811 |
| 86 | Failure to thrive in infancy (HP:0001531) | 1.99435168 |
| 87 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.98704339 |
| 88 | Sudden death (HP:0001699) | 1.98421619 |
| 89 | Distal lower limb amyotrophy (HP:0008944) | 1.98329902 |
| 90 | Tetraparesis (HP:0002273) | 1.98106884 |
| 91 | Congenital primary aphakia (HP:0007707) | 1.98039339 |
| 92 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97541575 |
| 93 | Hepatic necrosis (HP:0002605) | 1.97065248 |
| 94 | Pelvic girdle muscle weakness (HP:0003749) | 1.95987912 |
| 95 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94483210 |
| 96 | Anencephaly (HP:0002323) | 1.94381116 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 1.93087580 |
| 98 | Genetic anticipation (HP:0003743) | 1.92758920 |
| 99 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.92385891 |
| 100 | Hepatocellular necrosis (HP:0001404) | 1.92204791 |
| 101 | Protruding tongue (HP:0010808) | 1.92001057 |
| 102 | Ventricular tachycardia (HP:0004756) | 1.90205126 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 1.90067050 |
| 104 | Agammaglobulinemia (HP:0004432) | 1.87065673 |
| 105 | Abnormal drinking behavior (HP:0030082) | 1.86791206 |
| 106 | Polydipsia (HP:0001959) | 1.86791206 |
| 107 | Hypothermia (HP:0002045) | 1.86284227 |
| 108 | Hypercortisolism (HP:0001578) | 1.85506526 |
| 109 | Prostate neoplasm (HP:0100787) | 1.84525652 |
| 110 | Tinnitus (HP:0000360) | 1.84519313 |
| 111 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.83261014 |
| 112 | Prolonged QT interval (HP:0001657) | 1.83013054 |
| 113 | Genital tract atresia (HP:0001827) | 1.81371785 |
| 114 | Poor eye contact (HP:0000817) | 1.80958997 |
| 115 | Hemiparesis (HP:0001269) | 1.79776835 |
| 116 | Vaginal atresia (HP:0000148) | 1.79345843 |
| 117 | Left ventricular hypertrophy (HP:0001712) | 1.79118546 |
| 118 | Large for gestational age (HP:0001520) | 1.78600232 |
| 119 | Abnormal finger flexion creases (HP:0006143) | 1.78307521 |
| 120 | EMG: neuropathic changes (HP:0003445) | 1.77272634 |
| 121 | Difficulty walking (HP:0002355) | 1.77076648 |
| 122 | High anterior hairline (HP:0009890) | 1.76255408 |
| 123 | Excessive salivation (HP:0003781) | 1.74072145 |
| 124 | Drooling (HP:0002307) | 1.74072145 |
| 125 | Hypsarrhythmia (HP:0002521) | 1.72906274 |
| 126 | Distal arthrogryposis (HP:0005684) | 1.72643316 |
| 127 | Hematochezia (HP:0002573) | 1.72629260 |
| 128 | Macroorchidism (HP:0000053) | 1.72576760 |
| 129 | Abnormality of the calf musculature (HP:0001430) | 1.72266385 |
| 130 | Lower limb muscle weakness (HP:0007340) | 1.71504989 |
| 131 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.71261852 |
| 132 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.71261852 |
| 133 | Sclerocornea (HP:0000647) | 1.71134574 |
| 134 | Abnormality of the pubic bones (HP:0003172) | 1.70686409 |
| 135 | Broad-based gait (HP:0002136) | 1.70286856 |
| 136 | Ulnar claw (HP:0001178) | 1.69954593 |
| 137 | Abnormality of the aortic arch (HP:0012303) | 1.69723126 |
| 138 | Myotonia (HP:0002486) | 1.69367247 |
| 139 | Generalized tonic-clonic seizures (HP:0002069) | 1.68980170 |
| 140 | Lissencephaly (HP:0001339) | 1.68768948 |
| 141 | Recurrent skin infections (HP:0001581) | 1.68427524 |
| 142 | Progressive sensorineural hearing impairment (HP:0000408) | 1.68334842 |
| 143 | Absent phalangeal crease (HP:0006109) | 1.67836020 |
| 144 | Porencephaly (HP:0002132) | 1.66815610 |
| 145 | EEG with generalized epileptiform discharges (HP:0011198) | 1.66726160 |
| 146 | Severe muscular hypotonia (HP:0006829) | 1.65763700 |
| 147 | Acanthocytosis (HP:0001927) | 1.65171212 |
| 148 | Clumsiness (HP:0002312) | 1.65103645 |
| 149 | Muscle fiber splitting (HP:0003555) | 1.64844476 |
| 150 | Hypoplastic ischia (HP:0003175) | 1.64798588 |
| 151 | Septo-optic dysplasia (HP:0100842) | 1.64173787 |
| 152 | Abnormality of the frontal sinuses (HP:0002687) | 1.64122249 |
| 153 | Absence seizures (HP:0002121) | 1.63899912 |
| 154 | Agitation (HP:0000713) | 1.63895480 |
| 155 | Absent hand (HP:0004050) | 1.63292338 |
| 156 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.63183099 |
| 157 | Hypokalemia (HP:0002900) | 1.63089991 |
| 158 | Polymicrogyria (HP:0002126) | 1.62088699 |
| 159 | Elfin facies (HP:0004428) | 1.62064629 |
| 160 | Congenital hepatic fibrosis (HP:0002612) | 1.61075461 |
| 161 | Acute lymphatic leukemia (HP:0006721) | 1.60593499 |
| 162 | Pulmonary infiltrates (HP:0002113) | 1.60402096 |
| 163 | Abnormality of potassium homeostasis (HP:0011042) | 1.60303650 |
| 164 | EMG: myopathic abnormalities (HP:0003458) | 1.59753049 |
| 165 | Hyperphosphatemia (HP:0002905) | 1.59300495 |
| 166 | Epileptic encephalopathy (HP:0200134) | 1.58964554 |
| 167 | Hip dysplasia (HP:0001385) | 1.58713295 |
| 168 | Esotropia (HP:0000565) | 1.58246797 |
| 169 | Colitis (HP:0002583) | 1.57269831 |
| 170 | Short philtrum (HP:0000322) | 1.56773015 |
| 171 | Pheochromocytoma (HP:0002666) | 1.56658768 |
| 172 | Midline defect of the nose (HP:0004122) | 1.56097402 |
| 173 | Spastic paraplegia (HP:0001258) | 1.55816948 |
| 174 | Malignant hyperthermia (HP:0002047) | 1.55543095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.74970842 |
| 2 | MARK1 | 4.28896639 |
| 3 | FRK | 4.16143446 |
| 4 | STK38L | 4.04816828 |
| 5 | EPHB2 | 2.95763461 |
| 6 | EPHA3 | 2.77651668 |
| 7 | PINK1 | 2.76732409 |
| 8 | CHUK | 2.74354982 |
| 9 | MAP3K13 | 2.63294993 |
| 10 | SIK3 | 2.36810948 |
| 11 | BCR | 2.31160667 |
| 12 | ADRBK2 | 2.28277964 |
| 13 | LATS2 | 2.28277705 |
| 14 | WNK3 | 2.20719864 |
| 15 | PKN1 | 2.20181582 |
| 16 | IKBKB | 2.09933128 |
| 17 | CDK12 | 2.07108095 |
| 18 | KSR1 | 2.01385088 |
| 19 | OBSCN | 1.97861413 |
| 20 | DAPK2 | 1.96936854 |
| 21 | ERBB3 | 1.95939944 |
| 22 | DYRK2 | 1.94980242 |
| 23 | PRKAA2 | 1.92573524 |
| 24 | DYRK3 | 1.86124609 |
| 25 | MAP4K2 | 1.81691031 |
| 26 | TTN | 1.79812060 |
| 27 | ACVR1B | 1.76837884 |
| 28 | MAPK13 | 1.76284211 |
| 29 | PHKG1 | 1.75663906 |
| 30 | PHKG2 | 1.75663906 |
| 31 | SIK2 | 1.72999604 |
| 32 | NME1 | 1.66825654 |
| 33 | JAK3 | 1.65688841 |
| 34 | TYK2 | 1.61310459 |
| 35 | TNIK | 1.58030837 |
| 36 | GRK1 | 1.54244096 |
| 37 | BMPR1B | 1.54001736 |
| 38 | FGFR4 | 1.50738971 |
| 39 | NTRK3 | 1.41705069 |
| 40 | INSRR | 1.37812877 |
| 41 | FGFR3 | 1.37369237 |
| 42 | JAK1 | 1.35131370 |
| 43 | MAP2K7 | 1.34715429 |
| 44 | MAP3K4 | 1.32381780 |
| 45 | NTRK2 | 1.32043121 |
| 46 | CSNK1A1L | 1.10217184 |
| 47 | PRKD3 | 1.09949935 |
| 48 | IRAK4 | 1.09099712 |
| 49 | NUAK1 | 1.07078879 |
| 50 | IRAK1 | 1.05759703 |
| 51 | EPHB1 | 1.01398294 |
| 52 | MAP3K9 | 1.00574272 |
| 53 | EIF2AK2 | 1.00550013 |
| 54 | IKBKE | 1.00260211 |
| 55 | RET | 1.00181933 |
| 56 | SGK1 | 1.00081204 |
| 57 | TBK1 | 0.97976583 |
| 58 | CDC42BPA | 0.97636153 |
| 59 | STK3 | 0.97627872 |
| 60 | CASK | 0.96458143 |
| 61 | PRKCZ | 0.95864428 |
| 62 | DYRK1B | 0.95659201 |
| 63 | TLK1 | 0.95559206 |
| 64 | CCNB1 | 0.94648414 |
| 65 | CSNK1G2 | 0.93330406 |
| 66 | MAP2K4 | 0.92832278 |
| 67 | PTK6 | 0.91121515 |
| 68 | ICK | 0.90875719 |
| 69 | OXSR1 | 0.90697981 |
| 70 | EIF2AK3 | 0.88325390 |
| 71 | CSNK1G3 | 0.87536443 |
| 72 | DMPK | 0.85614154 |
| 73 | PAK3 | 0.83572512 |
| 74 | CSNK1G1 | 0.83135767 |
| 75 | TRIM28 | 0.82279236 |
| 76 | MAP2K6 | 0.81352741 |
| 77 | MAP3K7 | 0.77663152 |
| 78 | FLT3 | 0.77124353 |
| 79 | MAPKAPK3 | 0.74805519 |
| 80 | SGK2 | 0.73690338 |
| 81 | PRPF4B | 0.73204653 |
| 82 | TGFBR1 | 0.73201806 |
| 83 | DYRK1A | 0.70385215 |
| 84 | EPHA4 | 0.69801904 |
| 85 | MUSK | 0.69489023 |
| 86 | GRK7 | 0.67925002 |
| 87 | STK11 | 0.67487944 |
| 88 | PRKAA1 | 0.66151671 |
| 89 | FGFR2 | 0.66073163 |
| 90 | MKNK2 | 0.65353840 |
| 91 | BRD4 | 0.62091857 |
| 92 | IRAK2 | 0.61623016 |
| 93 | UHMK1 | 0.60921603 |
| 94 | RPS6KA1 | 0.60174785 |
| 95 | PIK3CG | 0.59394249 |
| 96 | AKT1 | 0.58973832 |
| 97 | CDK5 | 0.57685473 |
| 98 | ROCK1 | 0.56498089 |
| 99 | WNK4 | 0.55474540 |
| 100 | PRKCG | 0.55282739 |
| 101 | MAPKAPK2 | 0.55039707 |
| 102 | PAK6 | 0.54044812 |
| 103 | SGK223 | 0.53303762 |
| 104 | SGK494 | 0.53303762 |
| 105 | EEF2K | 0.52301179 |
| 106 | RPS6KA2 | 0.50703102 |
| 107 | STK38 | 0.49439461 |
| 108 | NLK | 0.48222105 |
| 109 | MINK1 | 0.47022515 |
| 110 | CAMK4 | 0.46731796 |
| 111 | CAMK2A | 0.45244099 |
| 112 | PRKCE | 0.44894023 |
| 113 | MAPK8 | 0.44781241 |
| 114 | SGK3 | 0.44302315 |
| 115 | YES1 | 0.44271160 |
| 116 | CDK3 | 0.43942753 |
| 117 | TAF1 | 0.43714959 |
| 118 | TNK2 | 0.43285314 |
| 119 | FGR | 0.42515498 |
| 120 | KIT | 0.42167770 |
| 121 | PRKACA | 0.41609770 |
| 122 | CSNK1D | 0.41383119 |
| 123 | SYK | 0.41175872 |
| 124 | LIMK1 | 0.40530918 |
| 125 | BMPR2 | 0.39889369 |
| 126 | CAMKK2 | 0.39820788 |
| 127 | TAOK3 | 0.39788763 |
| 128 | TYRO3 | 0.38829190 |
| 129 | MELK | 0.38078697 |
| 130 | AKT3 | 0.37681226 |
| 131 | WNK1 | 0.36770040 |
| 132 | MAP3K10 | 0.35568981 |
| 133 | PDGFRA | 0.35094896 |
| 134 | NEK2 | 0.35088844 |
| 135 | ROCK2 | 0.34749970 |
| 136 | CAMK1 | 0.34680732 |
| 137 | RPS6KA5 | 0.33489102 |
| 138 | CSNK1A1 | 0.31882883 |
| 139 | NEK9 | 0.31616966 |
| 140 | PRKCH | 0.31134185 |
| 141 | PTK2 | 0.30119508 |
| 142 | MAPK12 | 0.29976784 |
| 143 | PRKG1 | 0.29963110 |
| 144 | PLK2 | 0.28934764 |
| 145 | ZAK | 0.28331293 |
| 146 | GSK3B | 0.28293749 |
| 147 | GSK3A | 0.27944306 |
| 148 | CDK9 | 0.27445175 |
| 149 | ADRBK1 | 0.27422340 |
| 150 | TRPM7 | 0.27178381 |
| 151 | PRKCB | 0.26342580 |
| 152 | PTK2B | 0.26034014 |
| 153 | PRKACB | 0.25336036 |
| 154 | PRKCQ | 0.24369748 |
| 155 | TXK | 0.23918472 |
| 156 | LATS1 | 0.23905899 |
| 157 | MAP2K2 | 0.19471010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.36809775 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.83450701 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.56758738 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48500180 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.38519016 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32103899 |
| 7 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.09216314 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.07163439 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.81438419 |
| 10 | Axon guidance_Homo sapiens_hsa04360 | 1.74891009 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73888513 |
| 12 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.70518424 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.69798286 |
| 14 | Apoptosis_Homo sapiens_hsa04210 | 1.64686586 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.63649226 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.61387209 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61271641 |
| 18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60462924 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55762740 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51522966 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48897809 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.47283938 |
| 23 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.42860492 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41884185 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39754638 |
| 26 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38713822 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33880729 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33552814 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31946871 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31469149 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.31324491 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.29748403 |
| 33 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.29391561 |
| 34 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.29093832 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26019934 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.22976318 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.22726028 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21915013 |
| 39 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.19101641 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18708666 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14268828 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12713506 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09546387 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.08490033 |
| 45 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.08380444 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 1.07031424 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06084281 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05920021 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04813570 |
| 50 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04323387 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04291551 |
| 52 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04215125 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03564108 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03469967 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03071649 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99658797 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98719659 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98375760 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97986399 |
| 60 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.97698778 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97000877 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.96319864 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96210141 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.95553924 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95522076 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.95116491 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.93518748 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92641314 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91675677 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91556077 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91258331 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90065323 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.89619958 |
| 74 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89558027 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.89374013 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 0.88751812 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87698268 |
| 78 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87467846 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85804934 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85700339 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85234763 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84922144 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84726299 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84665533 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83938805 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83730943 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83583501 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.83247458 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.82986251 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82820920 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.82504407 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.81921685 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81893252 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.81834393 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.79695126 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79491493 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78689112 |
| 98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77066641 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76968889 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76862428 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76605576 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76547984 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76521077 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76452577 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.74835190 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74528892 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74499517 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74331093 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74327575 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73829950 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73094327 |
| 112 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72216597 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72207450 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70091047 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70044122 |
| 116 | GABAergic synapse_Homo sapiens_hsa04727 | 0.69449371 |
| 117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68329646 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66915506 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66833566 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66708983 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.66149952 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.65969470 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65851509 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63750665 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63680903 |
| 126 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63417899 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62797883 |
| 128 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.62427985 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62362976 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.62266678 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61873370 |
| 132 | Shigellosis_Homo sapiens_hsa05131 | 0.61835212 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61410554 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58940610 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58809308 |
| 136 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57517144 |
| 137 | Asthma_Homo sapiens_hsa05310 | 0.57053532 |
| 138 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56926976 |
| 139 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56863069 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56834194 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56134598 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55762044 |
| 143 | Hepatitis B_Homo sapiens_hsa05161 | 0.55650523 |
| 144 | Melanogenesis_Homo sapiens_hsa04916 | 0.55587770 |
| 145 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55005399 |
| 146 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.54940948 |
| 147 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.53623901 |
| 148 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52916284 |
| 149 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52192264 |
| 150 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51815189 |
| 151 | Peroxisome_Homo sapiens_hsa04146 | 0.48737237 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47063515 |
| 153 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.46390126 |
| 154 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45288065 |
| 155 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43938483 |
| 156 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43879781 |
| 157 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42620034 |
| 158 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42030329 |
| 159 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40717356 |
| 160 | Homologous recombination_Homo sapiens_hsa03440 | 0.39928200 |
| 161 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35760505 |
| 162 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34359478 |
| 163 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32173087 |
| 164 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31107194 |
| 165 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30617954 |
| 166 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30029666 |
| 167 | RNA degradation_Homo sapiens_hsa03018 | 0.27508153 |

